New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For CAT;BMY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 1, 2014
08:14 EDTBMYPortola announces Phase 3 ANNEXA study met primary, secondary endpoints
Subscribe for More Information
07:52 EDTBMYJ&J purchase of Alios an incremental negative for Achillion, says UBS
UBS views Johnson & Johnson's (JNJ) purchase of Alios as an incremental negative for Achillion (ACHN), as it implies there is now one less potential buyer of the company. However, the firm still thinks ACH-3422 will have considerable strategic value after data is reported and that other HCV players such as AbbVie (ABBV) and Bristol-Myers (BMY) are likely to be interested. UBS maintains its Buy rating and $15 price target on Achillion.
September 30, 2014
17:02 EDTBMYBristol-Myers to transfer $1.4B in U.S. pension obligations to Prudential
Subscribe for More Information
16:39 EDTBMYCMS discloses drug makers' payments to doctors, WSJ says
Subscribe for More Information
September 29, 2014
08:22 EDTBMYBristol-Myers says EMA validates MAA for Nivolumab in NSCLC
Bristol-Myers Squibb announced that the European Medicines Agency has validated for review the Marketing Authorization Application for nivolumab in non-small cell lung cancer– the first completed regulatory submission for a PD-1 immune checkpoint inhibitor in this tumor type. The MAA submitted to the EMA in lung cancer is based on data from the Phase 2 study of nivolumab in third-line pre-treated squamous cell NSCLC. In addition to the MAA for lung cancer in the E.U., the company previously announced that it has initiated a rolling submission with the FDA for Opdivo in third-line pre-treated squamous cell NSCLC and expects to complete the submission by year-end.
07:26 EDTBMYInforma Business Information to hold a conference
Subscribe for More Information
05:32 EDTBMYBristol-Myers announces positive Phase 3 data for Opdivo
Subscribe for More Information
September 26, 2014
16:20 EDTBMYBristol-Myers announces multiple regulatory milestones for Opdivo in U.S., EU
Subscribe for More Information
September 25, 2014
14:32 EDTCATGoldman Sachs close to acquiring Neovia Logistics for $1B, Reuters says
Subscribe for More Information
September 23, 2014
15:19 EDTCATCaterpillar close to triggering a bearish price pattern
There is a potential triple top, which resembles an irregularly-shaped bearish head and shoulders pattern, that is clearly visible on a 2-year chart. At the current price of $100.20, the pattern is close to triggering. Whether seen as a triple top or head and shoulders, the neckline is at $100. If there is a break below that level, the pattern would become active. Downside potential for the pattern, if it remained active and completed, would be to the $89 area. This would place shares close to the breakout point back in late January 2014. It would take a move back above $107 to void the pattern.
14:58 EDTCATCaterpillar looking for smaller deals in energy, transportation space
14:56 EDTCATCaterpillar backs FY14 EPS view $6.20, consensus $6.28
Subscribe for More Information
12:10 EDTBMYBristol-Myers to build 650,000 square foot campus in Lawrenceville, NJ
Subscribe for More Information
September 22, 2014
07:25 EDTCATCitigroup to hold a conference
Industrials Conference to be held in Boston on September 22-24.
07:21 EDTBMYEBD Group to hold a conference
Subscribe for More Information
September 19, 2014
11:11 EDTCATCaterpillar sales trends for August mixed, says Wells Fargo
Subscribe for More Information
09:13 EDTCATCaterpillar reports Machines sales down 10% in three months end August
Subscribe for More Information
September 17, 2014
07:43 EDTBMYBofA/Merrill to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use